A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation Academic Article uri icon

Overview

MeSH Major

  • Arteriovenous Shunt, Surgical
  • Carrier Proteins
  • Graft Occlusion, Vascular
  • Renal Dialysis
  • Thrombosis
  • Upper Extremity

abstract

  • PRT-201 was not different from placebo for safety or efficacy measures. There was a suggestion for improved AVF primary patency with Low Dose PRT-201 that is now being studied in a larger clinical trial.

publication date

  • April 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.5301/jva.5000125

PubMed ID

  • 23172172

Additional Document Info

start page

  • 143

end page

  • 51

volume

  • 14

number

  • 2